EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Regulatory T Cell Dysregulation in Vitiligo: A Meta‐Analysis and Systematic Review of Immune Mechanisms and Therapeutic Perspectives

Gabriela Lerner iD, Maria Nikolaou iD, Corinne Stoffel iD, Eloi Schmauch iD, Thomas Kündig iD, Thierry Passeron iD, Julien Seneschal iD, Nanja van Geel iD, Ulrike Held iD, Antonios G A Kolios iD

International Journal of Dermatology · 2025

DOI: 10.1111/ijd.17959 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Gabriela Lerner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Vitiligo, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitiligo is an autoimmune disorder marked by the progressive loss of skin melanocytes, increasingly linked to immune dysregulation as a key driver of disease onset and progression. Regulatory T (Treg) cells are essential for maintaining immune homeostasis by suppressing autoreactive immune responses. Mounting evidence implicates functional and numerical alterations in Treg cells in the pathogenesis of vitiligo. This study reviews findings on lesional and circulating Treg cells in vitiligo patients compared to healthy controls (HCs), examining Treg cell frequency, their ability to suppress CD4 + and CD8 + T cell activity, levels of the immunoregulatory cytokines interleukin‐10 (IL‐10) and transforming growth factor‐β (TGF‐β), expression of the key suppressive marker FOXP3, as well as levels of the pro‐inflammatory cytokines interleukin‐17 (IL‐17) and interleukin‐22 (IL‐22). A comprehensive systematic search was performed across Embase, MEDLINE/PubMed, and Scopus databases to identify eligible studies. A total of 21 studies comprising 1016 vitiligo patients and 846 HCs were included in the review. The analysis revealed a significant reduction in peripheral Treg cell counts ( p = 0.01), impaired overall suppressive capacity of CD4+ and CD8+ T cells ( p = 0.01), reduced levels of IL‐10 ( p = 0.02), increased levels of IL‐17 ( p ≤ 0.01) and IL‐22 ( p ≤ 0.01) in the blood of vitiligo patients compared to HCs. No statistically significant difference was observed in circulating TGF‐β levels ( p = 0.1). Most studies reported reduced FOXP3 expression in both skin and blood of vitiligo patients. Current evidence suggests vitiligo involves both reduced numbers and impaired function of Treg cells, supporting further study of Treg pathways as targets for immunomodulatory therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoT-Lymphocytes, RegulatoryHumansForkhead Transcription FactorsTransforming Growth Factor betaInterleukin-22CD8-Positive T-LymphocytesInterleukinsInterleukin-17Interleukin-10

Stichwörter der Autor:innen

FOXP3Treg cellsautoimmunitydermatologyimmune regulationimmunologyregulatory T‐cellsvitiligo

Substanzen

FOXP3 protein, humanForkhead Transcription FactorsTransforming Growth Factor betaInterleukin-22InterleukinsInterleukin-17Interleukin-10

Autor:innen und Institutionen

  • Department of Dermatology, University of Zurich, Zurich, Switzerland.
  • Institute of Pathology, Cantonal Hospital Winterthur, Winterthur, Switzerland.
  • Broad Institute of MIT and Harvard, Cambridge, USA.
  • Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, USA.
  • A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Department of Dermatology, University Côte d'Azur. CHU Nice, Nice, France.

ORCID-Profile: Gabriela Lerner, Maria Nikolaou, Corinne Stoffel, Eloi Schmauch, Thomas Kündig, Thierry Passeron, Julien Seneschal, Nanja van Geel, Ulrike Held, Antonios G A Kolios

Zitieren

APA

Lerner, G., Nikolaou, M., Stoffel, C., Schmauch, E., Kündig, T., Passeron, T., Seneschal, J., van Geel, N., Held, U., & Kolios, A. G. A. (2025). Regulatory T Cell Dysregulation in Vitiligo: A Meta‐Analysis and Systematic Review of Immune Mechanisms and Therapeutic Perspectives. International Journal of Dermatology. https://doi.org/10.1111/ijd.17959

Vancouver

Lerner G, Nikolaou M, Stoffel C, Schmauch E, Kündig T, Passeron T, et al. Regulatory T Cell Dysregulation in Vitiligo: A Meta‐Analysis and Systematic Review of Immune Mechanisms and Therapeutic Perspectives. International Journal of Dermatology. 2025. doi:10.1111/ijd.17959

BibTeX
@article{Lerner2025,
  author = {Lerner, Gabriela and Nikolaou, Maria and Stoffel, Corinne and Schmauch, Eloi and Kündig, Thomas and Passeron, Thierry and Seneschal, Julien and van Geel, Nanja and Held, Ulrike and Kolios, Antonios G A},
  title = {Regulatory T Cell Dysregulation in Vitiligo: A Meta‐Analysis and Systematic Review of Immune Mechanisms and Therapeutic Perspectives},
  journal = {International Journal of Dermatology},
  year = {2025},
  doi = {10.1111/ijd.17959}
}
Kostenlos starten →